Effect of enalapril maleate on cerebral blood flow in patients with chronic heart failure

Angiology. 1997 Aug;48(8):707-13. doi: 10.1177/000331979704800806.

Abstract

The effect of enalapril on cerebral blood flow (CBF) was studied in 11 patients with chronic heart failure (NYHA II or III, dilated cardiomyopathy in 6 and old myocardial infarction in 5). CBF was evaluated by analyzing the Patlak-Plot curve obtained from radionuclide angiography with technetium-99m hexamethylpropylene amine oxime (99mTC-HM-PAO). Cardiac index (CI) and stroke volume (SV) were simultaneously measured by impedance cardiography. These measurements were performed before and at four weeks after daily administration of 5 mg enalapril. The stroke volume, cardiac index, and heart rate were not significantly changed after four weeks of enalapril administration. However, CBF was increased by 6.5% from 36.72 +/- 4.66 to 39.13 +/- 5.65 mL/100g/min (P < 0.05). These results suggest that enalapril increased cerebral blood flow, which was not related to increased cardiac output in congestive heart failure. Patlak-Plot analysis of radionuclide angiography using 99mTC-HM-PAO may be available for quantitative assessment of brain perfusion.

MeSH terms

  • Aged
  • Angiotensin-Converting Enzyme Inhibitors / pharmacology*
  • Blood Flow Velocity / drug effects
  • Cardiac Output / drug effects
  • Cardiomyopathy, Dilated / drug therapy
  • Cardiomyopathy, Dilated / physiopathology
  • Cerebrovascular Circulation / drug effects*
  • Chronic Disease
  • Enalapril / pharmacology*
  • Female
  • Heart Failure / drug therapy
  • Heart Failure / physiopathology*
  • Heart Rate / drug effects
  • Humans
  • Male
  • Middle Aged
  • Organotechnetium Compounds
  • Oximes
  • Radionuclide Angiography
  • Stroke Volume / drug effects
  • Technetium Tc 99m Exametazime

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Organotechnetium Compounds
  • Oximes
  • Technetium Tc 99m Exametazime
  • Enalapril